FDA Admits to Massive Conflict of Interest
October 13, 2009
Spread the Word to
Friends And Family
By Sharing this Article.
The U.S. Food and Drug Administration admitted that four New Jersey congressmen and its own former commissioner unduly influenced the process that led to its decision last year to approve a patch for injured knees.
The agency’s scientific reviewers repeatedly and unanimously decided that the device, known as Menaflex and manufactured by ReGen Biologics, was unsafe because it often failed, forcing patients to get another operation.
But after receiving what an FDA report described as “extreme,” “unusual” and persistent pressure from four congressmen, agency managers overruled the scientists and approved the device for sale in December. All four legislators made their inquiries within a few months of receiving significant campaign contributions from ReGen, which is based in New Jersey.
The agency has never before publicly questioned the process behind one of its approvals, never admitted that a regulatory decision was influenced by politics, and never accused a former commissioner of questionable conduct.
Stay Up-To-Date on the Latest Health News
If you haven't already, here's your chance to subscribe to the world's most popular newsletter! My FREE newsletter is instrumental in changing the lives of many people across the world. If you want to take control of your health then you won't want to miss out on this opportunity.
When you subscribe I guarantee:
- You'll be the first to hear about fast-breaking health news and hard-to-find tips for improving your emotional, physical, and spiritual well-being
- You'll save money because I'm committed to helping you stay healthy, so you won't need expensive prescription drugs or doctor's visits so often
- You'll get straight talk from me in plain English that shatters all the myths and misconceptions about health, aging, and fitness
Don't be left in the dark on breaking health news! Sign up for my daily newsletter today!